When they investigated the effects of combinatorial signaling perturbations on intestinal cell fate, they found an unexpected and unexplained mutual antagonism between IL-4 and Epidermal growth factor receptor-inhibitor (EGFR-i) in the control of TAC numbers. This evidence concerns the gene EGFR and persistent truncus arteriosus.